These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 9393873

  • 1. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
    Hu MC, Qiu WR, Wang YP.
    Oncogene; 1997 Nov 06; 15(19):2277-87. PubMed ID: 9393873
    [Abstract] [Full Text] [Related]

  • 2. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.
    She QB, Ma WY, Dong Z.
    Oncogene; 2002 Feb 28; 21(10):1580-9. PubMed ID: 11896587
    [Abstract] [Full Text] [Related]

  • 3. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
    Fogarty MP, Downer EJ, Campbell V.
    Biochem J; 2003 May 01; 371(Pt 3):789-98. PubMed ID: 12534344
    [Abstract] [Full Text] [Related]

  • 4. Isoenzyme-specific protein kinase C and c-Jun N-terminal kinase activation by electrically stimulated contraction of neonatal rat ventricular myocytes.
    Strait JB, Samarel AM.
    J Mol Cell Cardiol; 2000 Aug 01; 32(8):1553-66. PubMed ID: 10900180
    [Abstract] [Full Text] [Related]

  • 5. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
    Oleinik NV, Krupenko NI, Krupenko SA.
    Oncogene; 2007 Nov 08; 26(51):7222-30. PubMed ID: 17525747
    [Abstract] [Full Text] [Related]

  • 6. Activation of c-Jun NH2-terminal kinases by interleukin-1 beta in normal human osteoblastic and rat UMR-106 cells.
    Chaudhary LR, Avioli LV.
    J Cell Biochem; 1998 Apr 01; 69(1):87-93. PubMed ID: 9513050
    [Abstract] [Full Text] [Related]

  • 7. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    Song JS, Haleem-Smith H, Arudchandran R, Gomez J, Scott PM, Mill JF, Tan TH, Rivera J.
    J Immunol; 1999 Jul 15; 163(2):802-10. PubMed ID: 10395673
    [Abstract] [Full Text] [Related]

  • 8. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway.
    Thomas A, Giesler T, White E.
    Oncogene; 2000 Nov 02; 19(46):5259-69. PubMed ID: 11077443
    [Abstract] [Full Text] [Related]

  • 9. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
    Katagiri C, Negishi K, Hibino T.
    J Dermatol Sci; 2006 Sep 02; 43(3):171-9. PubMed ID: 16824735
    [Abstract] [Full Text] [Related]

  • 10. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 02; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 11. Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway.
    Huang C, Ma WY, Li J, Dong Z.
    Cancer Res; 1999 Jul 01; 59(13):3053-8. PubMed ID: 10397243
    [Abstract] [Full Text] [Related]

  • 12. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.
    She QB, Chen N, Bode AM, Flavell RA, Dong Z.
    Cancer Res; 2002 Mar 01; 62(5):1343-8. PubMed ID: 11888903
    [Abstract] [Full Text] [Related]

  • 13. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E, Boldyreff B, Scheidtmann KH.
    Oncogene; 1993 Aug 01; 8(8):2193-205. PubMed ID: 8393163
    [Abstract] [Full Text] [Related]

  • 14. Differential phosphorylations of Spi-B and Spi-1 transcription factors.
    Mao C, Ray-Gallet D, Tavitian A, Moreau-Gachelin F.
    Oncogene; 1996 Feb 15; 12(4):863-73. PubMed ID: 8632909
    [Abstract] [Full Text] [Related]

  • 15. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
    Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, Hibi M, Nakabeppu Y, Shiba T, Yamamoto KI.
    Mol Cell Biol; 1999 Nov 15; 19(11):7539-48. PubMed ID: 10523642
    [Abstract] [Full Text] [Related]

  • 16. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E, Scheidtmann KH.
    Oncogene; 1995 Mar 16; 10(6):1175-85. PubMed ID: 7700642
    [Abstract] [Full Text] [Related]

  • 17. Human c-Jun N-terminal kinase expression and activation in the nervous system.
    Kumagae Y, Zhang Y, Kim OJ, Miller CA.
    Brain Res Mol Brain Res; 1999 Apr 06; 67(1):10-7. PubMed ID: 10101227
    [Abstract] [Full Text] [Related]

  • 18. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L, Meek DW.
    Cell Mol Biol Res; 1994 Apr 06; 40(5-6):555-61. PubMed ID: 7735330
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK).
    Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M.
    J Neurochem; 2004 Jul 06; 90(2):352-8. PubMed ID: 15228592
    [Abstract] [Full Text] [Related]

  • 20. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
    Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, Hoekstra MF, Meek DW.
    Oncogene; 1997 Oct 02; 15(14):1727-36. PubMed ID: 9349507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.